12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites

12 standard quality house dust mite sublingual lyophilisate (SQ-HDM SLIT; Acarizax, ALK-Abello) is indicated 'in adult patients (18-65 years) diagnosed by clinical history and a positive test of house dust mite sensitisation (skin prick test and/or specific IgE) with at least one of the following conditions:

• persistent moderate to severe house dust mite allergic rhinitis despite use of symptom-relieving medication

• house dust mite allergic asthma not well controlled by inhaled corticosteroids and associated with mild to severe house dust mite allergic rhinitis. Patients' asthma status should be carefully evaluated before the initiation of treatment'.
  
  12 SQ-HDM SLIT is also indicated 'in adolescents (12-17 years) diagnosed by clinical history and a positive test of house dust mite sensitisation (skin prick test and/or specific IgE) with persistent moderate to severe house dust mite allergic rhinitis despite use of symptom-relieving medication'.

The dosage schedule is available in the summary of product characteristics for 12 SQ-HDM SLIT.

The list price of 12 SQ‑HDM SLIT is £80.12 (excluding VAT; BNF accessed April 2024) per pack of 30 tablets. Costs may vary in different settings because of negotiated procurement discounts.